ID: ALA4575540

Max Phase: Preclinical

Molecular Formula: C17H21N3O2S

Molecular Weight: 331.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(-c2nc(NS(C)(=O)=O)cc3c2CCCN3)c1C

Standard InChI:  InChI=1S/C17H21N3O2S/c1-11-6-4-7-13(12(11)2)17-14-8-5-9-18-15(14)10-16(19-17)20-23(3,21)22/h4,6-7,10,18H,5,8-9H2,1-3H3,(H,19,20)

Standard InChI Key:  GLMQIIJYKOFTBX-UHFFFAOYSA-N

Associated Targets(Human)

7,8-dihydro-8-oxoguanine triphosphatase 280 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.44Molecular Weight (Monoisotopic): 331.1354AlogP: 3.10#Rotatable Bonds: 3
Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.98CX Basic pKa: 0.88CX LogP: 2.74CX LogD: 2.65
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.91Np Likeness Score: -0.76

References

1. Farand J, Kropf JE, Blomgren P, Xu J, Schmitt AC, Newby ZE, Wang T, Murakami E, Barauskas O, Sudhamsu J, Feng JY, Niedziela-Majka A, Schultz BE, Schwartz K, Viatchenko-Karpinski S, Kornyeyev D, Kashishian A, Fan P, Chen X, Lansdon EB, Ports MO, Currie KS, Watkins WJ, Notte GT..  (2020)  Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation.,  11  (3): [PMID:32184970] [10.1021/acsmedchemlett.9b00420]

Source